9OM3 | pdb_00009om3

Two Component Protein Nano-Particle (T=3). De Novo Design, Computationally Relaxed into Low Resolution Single Particle CryoEM Map with Icosahedral Symmetry Applied

  • Classification: DE NOVO PROTEIN
  • Organism(s): synthetic construct
  • Expression System: Escherichia coli 'BL21-Gold(DE3)pLysS AG
  • Mutation(s): No 

  • Deposited: 2025-05-13 Released: 2026-05-20 
  • Deposition Author(s): DiMaio, F., Weidle, C.
  • Funding Organization(s): Defense Threat Reduction Agency (DTRA), Burroughs Wellcome Fund, Human Frontier Science Program (HFSP), Bill & Melinda Gates Foundation, Howard Hughes Medical Institute (HHMI), National Institutes of Health/National Institute on Aging (NIH/NIA), Department of Energy (DOE, United States)

Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 17.4 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9OM3

This is version 1.1 of the entry. See complete history

Literature

De novo design of quasisymmetric two-component protein cages.

Wang, S.Xie, Y.Chemielewski, D.Weidle, C.Shu, T.Ahn, G.Kibler, R.D.Hernandez, C.Chen, W.Duran, D.C.Carr, A.Bera, A.K.Lee, S.Decarreau, J.Kang, A.Brackenbrough, E.Joyce, E.Wu, K.Borst, A.J.Favor, A.Huang, B.DiMaio, F.Holt, L.J.Baker, D.

(2026) Nature 

  • DOI: https://doi.org/10.1038/s41586-026-10464-0
  • Primary Citation Related Structures: 
    9NDL, 9OM3, 9OP9

  • PubMed Abstract: 

    Quasisymmetric icosahedral viral capsids achieve larger sizes than possible with strictly symmetric icosahedra by tessellating pentagons and hexagons using a single subunit that adopts different conformations in symmetrically non-equivalent locations 1,2 . Recapitulating such quasisymmetric architectures through computational design is a considerable challenge in nanomaterials engineering. Here we introduce a computational design strategy based on geometric frustration to generate two-component, quasisymmetric protein cages with customizable properties. We designed complementary trimeric and dimeric protein components that co-assemble into positively curved local hexagonal assemblies. Hexagonal lattices cannot tile spherical surfaces; instead, the components form closed sphere-like cage assemblies through incorporation of curvature-inducing pentagonal defects, as evidenced by electron microscopy. By designing dimers that encode different local curvatures, we programmed cage dimensions ranging from 40 to over 200 nm in diameter and with molecular weights from 2 MDa to over 50 MDa, comparable with natural virus capsids. We further functionalized these large cages with additional protein domains to enable ribonucleoprotein cargo loading and cellular uptake. Fluorescently labelled cage assemblies expressed in mammalian cells function as rheological probes and cargo recruiters, enabling a systematic study of size-dependent cytoplasmic diffusion and protein localization. Thus, the quasi-symmetry that has long fascinated structural biologists can now be achieved by computational protein design, with immediate applications to biologics delivery and molecular cell biology.


  • Organizational Affiliation
    • Department of Biochemistry, University of Washington, Seattle, WA, USA. shunzhi.wang@nyulangone.org.

Macromolecule Content 

  • Total Structure Weight: 8,275.13 kDa 
  • Atom Count: 553,500 
  • Modeled Residue Count: 71,640 
  • Deposited Residue Count: 74,520 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
C2-B
A,
AA [auth a],
AB [auth ZA],
AC [auth AQ],
AD [auth Aq],
AE [auth BG],
AF [auth Bg],
AG [auth YA],
AH [auth CW],
AI [auth Cw],
AJ [auth DM],
AK [auth Dm],
AL [auth EC],
AM [auth Ec],
C,
CA [auth c],
CB [auth ZC],
CC [auth AS],
CD [auth As],
CE [auth BI],
CF [auth Bi],
CG [auth YC],
CH [auth CY],
CI [auth Cy],
CJ [auth DO],
CK [auth Do],
CL [auth EE],
CM [auth Ee],
E,
EA [auth e],
EB [auth ZE],
EC [auth AU],
ED [auth Au],
EE [auth BK],
EF [auth Bk],
EG [auth CA],
EH [auth Ca],
EI [auth YE],
EJ [auth DQ],
EK [auth Dq],
EL [auth EG],
EM [auth Eg],
G,
GA [auth g],
GB [auth ZG],
GC [auth AW],
GD [auth Aw],
GE [auth BM],
GF [auth Bm],
GG [auth CC],
GH [auth Cc],
GI [auth YG],
GJ [auth DS],
GK [auth Ds],
GL [auth EI],
GM [auth Ei],
I,
IA [auth i],
IB [auth ZI],
IC [auth AY],
ID [auth Ay],
IE [auth BO],
IF [auth Bo],
IG [auth CE],
IH [auth Ce],
II [auth YI],
IJ [auth DU],
IK [auth Du],
IL [auth EK],
IM [auth Ek],
K,
KA [auth k],
KB [auth AA],
KC [auth Aa],
KD [auth ZK],
KE [auth BQ],
KF [auth Bq],
KG [auth CG],
KH [auth Cg],
KI [auth YK],
KJ [auth DW],
KK [auth Dw],
KL [auth EM],
KM [auth Em],
M,
MA [auth m],
MB [auth AC],
MC [auth Ac],
MD [auth ZM],
ME [auth BS],
MF [auth Bs],
MG [auth CI],
MH [auth Ci],
MI [auth YM],
MJ [auth DY],
MK [auth Dy],
ML [auth EO],
MM [auth Eo],
O,
OA [auth o],
OB [auth AE],
OC [auth Ae],
OD [auth ZO],
OE [auth BU],
OF [auth Bu],
OG [auth CK],
OH [auth Ck],
OI [auth DA],
OJ [auth Da],
OK [auth YO],
OL [auth EQ],
OM [auth Eq],
Q,
QA [auth q],
QB [auth AG],
QC [auth Ag],
QD [auth ZQ],
QE [auth BW],
QF [auth Bw],
QG [auth CM],
QH [auth Cm],
QI [auth DC],
QJ [auth Dc],
QK [auth YQ],
QL [auth ES],
QM [auth Es],
S,
SA [auth s],
SB [auth AI],
SC [auth Ai],
SD [auth ZS],
SE [auth BY],
SF [auth By],
SG [auth CO],
SH [auth Co],
SI [auth DE],
SJ [auth De],
SK [auth YS],
SL [auth EU],
SM [auth Eu],
U,
UA [auth u],
UB [auth AK],
UC [auth Ak],
UD [auth BA],
UE [auth Ba],
UF [auth ZU],
UG [auth CQ],
UH [auth Cq],
UI [auth DG],
UJ [auth Dg],
UK [auth YU],
UL [auth EW],
UM [auth Ew],
W,
WA [auth w],
WB [auth AM],
WC [auth Am],
WD [auth BC],
WE [auth Bc],
WF [auth ZW],
WG [auth CS],
WH [auth Cs],
WI [auth DI],
WJ [auth Di],
WK [auth YW],
WL [auth EY],
Y,
YA [auth y],
YB [auth AO],
YC [auth Ao],
YD [auth BE],
YE [auth Be],
YF [auth ZY],
YG [auth CU],
YH [auth Cu],
YI [auth DK],
YJ [auth Dk],
YK [auth EA],
YL [auth Ea]
114synthetic constructMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
C3-A
B,
BA [auth b],
BB [auth ZB],
BC [auth AR],
BD [auth Ar],
BE [auth BH],
BF [auth Bh],
BG [auth YB],
BH [auth CX],
BI [auth Cx],
BJ [auth DN],
BK [auth Dn],
BL [auth ED],
BM [auth Ed],
D,
DA [auth d],
DB [auth ZD],
DC [auth AT],
DD [auth At],
DE [auth BJ],
DF [auth Bj],
DG [auth YD],
DH [auth CZ],
DI [auth Cz],
DJ [auth DP],
DK [auth Dp],
DL [auth EF],
DM [auth Ef],
F,
FA [auth f],
FB [auth ZF],
FC [auth AV],
FD [auth Av],
FE [auth BL],
FF [auth Bl],
FG [auth CB],
FH [auth Cb],
FI [auth YF],
FJ [auth DR],
FK [auth Dr],
FL [auth EH],
FM [auth Eh],
H,
HA [auth h],
HB [auth ZH],
HC [auth AX],
HD [auth Ax],
HE [auth BN],
HF [auth Bn],
HG [auth CD],
HH [auth Cd],
HI [auth YH],
HJ [auth DT],
HK [auth Dt],
HL [auth EJ],
HM [auth Ej],
J,
JA [auth j],
JB [auth ZJ],
JC [auth AZ],
JD [auth Az],
JE [auth BP],
JF [auth Bp],
JG [auth CF],
JH [auth Cf],
JI [auth YJ],
JJ [auth DV],
JK [auth Dv],
JL [auth EL],
JM [auth El],
L,
LA [auth l],
LB [auth AB],
LC [auth Ab],
LD [auth ZL],
LE [auth BR],
LF [auth Br],
LG [auth CH],
LH [auth Ch],
LI [auth YL],
LJ [auth DX],
LK [auth Dx],
LL [auth EN],
LM [auth En],
N,
NA [auth n],
NB [auth AD],
NC [auth Ad],
ND [auth ZN],
NE [auth BT],
NF [auth Bt],
NG [auth CJ],
NH [auth Cj],
NI [auth YN],
NJ [auth DZ],
NK [auth Dz],
NL [auth EP],
NM [auth Ep],
P,
PA [auth p],
PB [auth AF],
PC [auth Af],
PD [auth ZP],
PE [auth BV],
PF [auth Bv],
PG [auth CL],
PH [auth Cl],
PI [auth DB],
PJ [auth Db],
PK [auth YP],
PL [auth ER],
PM [auth Er],
R,
RA [auth r],
RB [auth AH],
RC [auth Ah],
RD [auth ZR],
RE [auth BX],
RF [auth Bx],
RG [auth CN],
RH [auth Cn],
RI [auth DD],
RJ [auth Dd],
RK [auth YR],
RL [auth ET],
RM [auth Et],
T,
TA [auth t],
TB [auth AJ],
TC [auth Aj],
TD [auth ZT],
TE [auth BZ],
TF [auth Bz],
TG [auth CP],
TH [auth Cp],
TI [auth DF],
TJ [auth Df],
TK [auth YT],
TL [auth EV],
TM [auth Ev],
V,
VA [auth v],
VB [auth AL],
VC [auth Al],
VD [auth BB],
VE [auth Bb],
VF [auth ZV],
VG [auth CR],
VH [auth Cr],
VI [auth DH],
VJ [auth Dh],
VK [auth YV],
VL [auth EX],
VM [auth Ex],
X,
XA [auth x],
XB [auth AN],
XC [auth An],
XD [auth BD],
XE [auth Bd],
XF [auth ZX],
XG [auth CT],
XH [auth Ct],
XI [auth DJ],
XJ [auth Dj],
XK [auth YX],
XL [auth EZ],
Z,
ZA [auth z],
ZB [auth AP],
ZC [auth Ap],
ZD [auth BF],
ZE [auth Bf],
ZF [auth ZZ],
ZG [auth CV],
ZH [auth Cv],
ZI [auth DL],
ZJ [auth Dl],
ZK [auth EB],
ZL [auth Eb]
300synthetic constructMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 17.4 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONcryoSPARC
MODEL REFINEMENTPHENIX1.21.2_5419

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Defense Threat Reduction Agency (DTRA)United StatesHDTRA1-19-1-0003
Burroughs Wellcome FundUnited States--
Human Frontier Science Program (HFSP)FranceRGP0061/2019
Bill & Melinda Gates FoundationUnited StatesINV-043758
Bill & Melinda Gates FoundationUnited StatesOPP1156262
Howard Hughes Medical Institute (HHMI)United States--
National Institutes of Health/National Institute on Aging (NIH/NIA)United StatesR01AG063845
Department of Energy (DOE, United States)United StatesKP1607011

Revision History  (Full details and data files)

  • Version 1.0: 2026-05-20
    Type: Initial release
  • Version 1.1: 2026-06-03
    Changes: Data collection, Database references